Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
about
Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cellsRole of Peroxisome Proliferator-Activated Receptors in Inflammation ControlInhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes.Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Treatment of coexisting diabetes and hypertension.Novel insulin sensitizers: pharmacogenomic aspects.Vascular effects of GI262570X (PPAR-gamma agonist) in the brown adipose tissue of Han Wistar rats: a review of 1-month, 13-week, 27-week and 2-year oral toxicity studies.Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.PPAR Agonists and Cardiovascular Disease in Diabetes.Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.New approaches to the treatment of nephropathy in diabetes.The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins.PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
P2860
Q24294541-FD86FC79-7861-4293-A9CE-E130071DC6D7Q24796541-0137B05C-CA20-4E20-B074-FC3BCBB2725BQ28218456-D77E7883-5275-43D3-A7E1-42850827B515Q31566836-18826E4E-AC22-4B1A-A5B4-8C314597E5ECQ34107495-A704F938-0740-488D-8BCF-7A5B6A2CC5DEQ34290988-3FB1C00B-F7CB-4704-82F0-B662498F39D6Q34401849-976D02AB-6E2F-4B1A-8BF9-2EFAF2686ED0Q34609164-13B1A564-0D7F-4B79-AF82-0C6C0A93AD01Q34790065-4AD57A10-7C61-4A2C-86A9-8CE391BF0ECFQ35030013-E14E1FDF-7417-489D-9349-E505B88A70DFQ36068458-5E8A3D71-70EA-437A-BCFE-0FF827A52BE5Q36444975-48A595AD-3F48-46A2-A7D4-EC6C8E7AEDC6Q36684479-9E246353-F77C-4411-A3C0-9B3611444739Q37899907-6A34A411-318F-45D0-8E61-A884FE97FEE4Q37997004-5E82FAA1-6307-42D9-BF34-1974ECA372AAQ38347071-5F36A29E-8648-444C-ADE9-953E1094BCECQ38359904-43F41E63-C3DA-4DEC-83C2-FD35E069F986Q44006856-2464056F-CDEE-416F-B4D5-4122F4D5C1B6Q44582172-F1FF6667-BE1F-43F7-AA94-018CB67FB569Q50773167-2EF69CED-E9F4-423E-8A9D-B216C12D2A3D
P2860
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@ast
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@en
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@nl
type
label
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@ast
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@en
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@nl
prefLabel
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@ast
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@en
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@nl
P2093
P356
P1433
P1476
Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
@en
P2093
P356
10.1161/01.HYP.33.4.943
P407
P577
1999-04-01T00:00:00Z